Technical Analysis for MTEM - Molecular Templates, Inc.

Grade Last Price % Change Price Change
F 0.46 1.73% 0.01
MTEM closed up 1.73 percent on Friday, November 1, 2024, on 1 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 11
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 1.73%
Doji - Bullish? Reversal 1.73%
Wide Bands Range Expansion 1.73%
Oversold Stochastic Weakness 1.73%
NR7 Range Contraction 1.73%
Narrow Range Bar Range Contraction 1.73%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 17 hours ago
Up 1% about 20 hours ago
Possible NR7 1 day ago
Possible NR7 3 days ago
Up 1% 3 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is headquartered in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Treatment Of Cancer Cancer Treatment Oncology Chemical Elements Lymphoma Oxygen Toxins Prodrugs Evofosfamide Prodrug Nitrogen Mustards

Is MTEM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.25
52 Week Low 0.295
Average Volume 5,336,676
200-Day Moving Average 1.83
50-Day Moving Average 1.14
20-Day Moving Average 0.78
10-Day Moving Average 0.57
Average True Range 0.13
RSI (14) 33.33
ADX 17.89
+DI 28.37
-DI 36.90
Chandelier Exit (Long, 3 ATRs) 1.09
Chandelier Exit (Short, 3 ATRs) 0.69
Upper Bollinger Bands 1.61
Lower Bollinger Band -0.05
Percent B (%b) 0.3
BandWidth 211.70
MACD Line -0.22
MACD Signal Line -0.20
MACD Histogram -0.0172
Fundamentals Value
Market Cap 2.46 Million
Num Shares 5.37 Million
EPS -6.92
Price-to-Earnings (P/E) Ratio -0.07
Price-to-Sales 0.36
Price-to-Book 2.77
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.47
Resistance 3 (R3) 0.47 0.47 0.47
Resistance 2 (R2) 0.47 0.46 0.47 0.47
Resistance 1 (R1) 0.46 0.46 0.46 0.46 0.47
Pivot Point 0.46 0.46 0.46 0.46 0.46
Support 1 (S1) 0.45 0.45 0.45 0.45 0.45
Support 2 (S2) 0.45 0.45 0.45 0.45
Support 3 (S3) 0.44 0.45 0.45
Support 4 (S4) 0.44